BridgeMD
New treatment option for Ovarian Neoplasms
Official title Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)
ClinicalTrials.gov ID: NCT06963268
What this study is testing
- What it's testing
- This clinical trial investigates the sentinel lymph node (SLN) technique as a less invasive alternative to conventional lymphadenectomy in patients with early-stage ovarian cancer. The primary objective is to evaluate the effectiveness, safety, and diagnostic accuracy of the SLN approach in detecting lymphatic metastases.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Signed informed consent prior to the performance of any procedure related to the clinical trial.
- Female, 18 years of age or older at the time of inclusion.
- Patients with a histopathological diagnosis of malignant ovarian tumor in a deferred study (any epithelial histology), in apparent early stage FIGO...
You likely can't join if
- Failure to obtain informed consent or revocation of informed consent.
- Under 18 years of age at the time of inclusion.
- Previous history of vascular surgery on the aorta, vena cava, or pelvic vessels.
- Previous pelvic or paraaortic lymphatic surgery.
- Previous lymphoma.
- Previous abdomino-pelvic tumor.
See the full eligibility criteria
- Signed informed consent prior to the performance of any procedure related to the clinical trial.
- Female, 18 years of age or older at the time of inclusion.
- Patients with a histopathological diagnosis of malignant ovarian tumor in a deferred study (any epithelial histology), in apparent early stage FIGO I-II, proposed for staging surgery, or patients with suspected...
- Failure to obtain informed consent or revocation of informed consent.
- Under 18 years of age at the time of inclusion.
- Previous history of vascular surgery on the aorta, vena cava, or pelvic vessels.
- Previous pelvic or paraaortic lymphatic surgery.
- Previous lymphoma.
- Previous abdomino-pelvic tumor.
- Previous allergy to Tc99 or ICG.
- Pregnancy/Breastfeeding. Patients who have signed informed consent but do not meet all inclusion criteria and none of the exclusion criteria will be considered as selection failures.
The study team makes the final eligibility decision.
Where it's taking place
- Valencia, Valencia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valencia, Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.